SR One closes second venture fund at $600m
The VC firm will use the capital to continue supporting emerging biotech companies.
Archives for April 6, 2023
Avid Bioservices unveils mammalian cell facilities expansion
Avid Bioservices, a dedicated biologics CDMO in the US, has completed two expansions within the company’s mammalian cell facilities
Facing tough markets, Freeline Therapeutics drops Fabry disease gene therapy and lays off 30% of workforce
In an effort to improve its cash runway, the UK biotech company Freeline Therapeutics has paused the development of a gene therapy candidate for the rare metabolic condition Fabry disease. Instead, the company will refocus its efforts on a gene therapy...
Meissner to build new $250m manufacturing facility in Athens, Georgia
Meissner Corporation – a company which manufactures advanced microfiltration and therapeutic manufacturing systems for pharmaceutical drugs, therapeutics, biologics, and cell and gene therapies - will invest nearly $250m in a new manufacturing facility...
New treatment for critically ill COVID-19 patients receives EUA in the US
InflaRx’s Gohibic (vilobelimab), a monoclonal anti-human complement factor C5a antibody, has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for the treatment of COVID-19 in hospitalized adults.